Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies
Authors
Keywords
-
Journal
World Journal of Stem Cells
Volume 11, Issue 11, Pages 920-936
Publisher
Baishideng Publishing Group Inc.
Online
2019-11-01
DOI
10.4252/wjsc.v11.i11.920
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of epigenetic therapies in colorectal cancer
- (2018) Marina Baretti et al. CURRENT PROBLEMS IN CANCER
- Small molecule KDM4s inhibitors as anti-cancer agents
- (2018) Hongzhi Lin et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)
- (2018) H. Ümit Kaniskan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of potent dual inhibitors of JAK2 and HDAC based on fusing the pharmacophores of XL019 and vorinostat
- (2018) Yu-yi Chu-Farseeva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer
- (2018) David Fogelman et al. Cancer Medicine
- Potential mechanisms of CD133 in cancer stem cells
- (2017) Jae-Woo Jang et al. LIFE SCIENCES
- The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
- (2017) Yupeng He et al. Nature Chemical Biology
- LinkedOmics: analyzing multi-omics data within and across 32 cancer types
- (2017) Suhas V Vasaikar et al. NUCLEIC ACIDS RESEARCH
- Peptide inhibition of the SETD6 methyltransferase catalytic activity
- (2017) Michal Feldman et al. Oncotarget
- Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat: a phase 2 consortium/stand Up 2 cancer study
- (2017) Nilofer S. Azad et al. Oncotarget
- Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
- (2017) Anup Sharma et al. PLoS One
- Discovery of a PCAF Bromodomain Chemical Probe
- (2016) Moses Moustakim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Structural basis of arginine asymmetrical dimethylation by PRMT6
- (2016) H. Wu et al. BIOCHEMICAL JOURNAL
- In vitro models of cancer stem cells and clinical applications
- (2016) Sara S. Franco et al. BMC CANCER
- GPX3 promoter methylation predicts platinum sensitivity in colorectal cancer
- (2016) Lorraine Pelosof et al. Epigenetics
- Bromodomain inhibitors and cancer therapy: From structures to applications
- (2016) Montserrat Pérez-Salvia et al. Epigenetics
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin
- (2016) Michael J. Overman et al. Oncotarget
- Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer
- (2016) Shusuke Toden et al. Oncotarget
- Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
- (2016) Matthieu Corvaisier et al. Oncotarget
- Prognostic significance of CD44 in human colon cancer and gastric cancer: Evidence from bioinformatic analyses
- (2016) Pu Xia et al. Oncotarget
- Histone acetyltransferases: challenges in targeting bi-substrate enzymes
- (2016) Hannah Wapenaar et al. Clinical Epigenetics
- Inferring mutational timing and reconstructing tumour evolutionary histories
- (2015) Samra Turajlic et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways
- (2015) Jie Wang et al. Gastroenterology Research and Practice
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma
- (2015) Dae-Woon Eom et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone deacetylase inhibitor valproic acid in patients with advanced cancers
- (2014) Jennifer J. Wheler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors
- (2014) Nuttapong Ngamphaiboon et al. INVESTIGATIONAL NEW DRUGS
- Harnessing the potential of epigenetic therapy to target solid tumors
- (2014) Nita Ahuja et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of Human Donor Cell Source on Differentiation and Function of Cardiac Induced Pluripotent Stem Cells
- (2014) Veronica Sanchez-Freire et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer
- (2014) J Tan et al. Cell Death & Disease
- Colon Cancer Cells Escape 5FU Chemotherapy-Induced Cell Death by Entering Stemness and Quiescence Associated with the c-Yes/YAP Axis
- (2013) Y. Touil et al. CLINICAL CANCER RESEARCH
- Therapy-induced enrichment of putative lung cancer stem-like cells
- (2013) Daniela P. Freitas et al. INTERNATIONAL JOURNAL OF CANCER
- A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer
- (2013) I. Garrido-Laguna et al. INVESTIGATIONAL NEW DRUGS
- A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors
- (2013) Dustin A. Deming et al. INVESTIGATIONAL NEW DRUGS
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
- (2013) J Zeilstra et al. ONCOGENE
- SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis
- (2013) Raul Aguirre-Gamboa et al. PLoS One
- CD133: A cancer stem cells marker, is used in colorectal cancers
- (2013) Fei Ren WORLD JOURNAL OF GASTROENTEROLOGY
- Zebularine inhibits tumorigenesis and stemness of colorectal cancer via p53-dependent endoplasmic reticulum stress
- (2013) Pei-Ming Yang et al. Scientific Reports
- On the epigenetic origin of cancer stem cells
- (2012) Audrey Vincent et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Dynamic equilibrium between cancer stem cells and non-stem cancer cells in human SW620 and MCF-7 cancer cell populations
- (2012) G Yang et al. BRITISH JOURNAL OF CANCER
- Phase I study of bevacizumab, everolimus, and panobinostat (LBH-589) in advanced solid tumors
- (2012) John H. Strickler et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
- (2012) M. Mao et al. CLINICAL CANCER RESEARCH
- Discovery of Salermide-Related Sirtuin Inhibitors: Binding Mode Studies and Antiproliferative Effects in Cancer Cells Including Cancer Stem Cells
- (2012) Dante Rotili et al. JOURNAL OF MEDICINAL CHEMISTRY
- Radiation-Induced Reprogramming of Breast Cancer Cells
- (2012) Chann Lagadec et al. STEM CELLS
- EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter
- (2012) Lilian E. van Vlerken et al. Stem Cells Translational Medicine
- Clinical trials of resveratrol
- (2011) Ketan R. Patel et al. Annals of the New York Academy of Sciences
- Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
- (2011) R Pili et al. BRITISH JOURNAL OF CANCER
- A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
- (2011) M. G. Fakih et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies
- (2011) Julie Bauman et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells
- (2011) Ori Bar-Nur et al. Cell Stem Cell
- Microarray-based analysis of microRNA expression in breast cancer stem cells
- (2011) Jian-guo Sun et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histone H3 lysine 9 trimethylation and HP1γ favor inclusion of alternative exons
- (2011) Violaine Saint-André et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Distinct Epigenetic Profiling in Head and Neck Squamous Cell Carcinoma Stem Cells
- (2011) Jun Furusawa et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications
- (2010) Imke Müller et al. BMC CANCER
- A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapy
- (2010) Peter M. Wilson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors
- (2010) Soejima INTERNATIONAL JOURNAL OF ONCOLOGY
- Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
- (2010) Anne Hansen Ree et al. LANCET ONCOLOGY
- Mechanisms of transcriptional regulation and prognostic significance of activated leukocyte cell adhesion molecule in cancer
- (2010) Judy A King et al. Molecular Cancer
- Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
- (2010) Anne M Friel et al. Reproductive Biology and Endocrinology
- Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker
- (2009) P N Munster et al. BRITISH JOURNAL OF CANCER
- Prognostic Significance of the Cancer Stem Cell Markers CD133, CD44, and CD166 in Colorectal Cancer
- (2009) David Horst et al. CANCER INVESTIGATION
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
- (2009) Mark Shackleton et al. CELL
- Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
- (2009) G. Bar-Sela et al. CURRENT MEDICINAL CHEMISTRY
- Promoter hypomethylation regulates CD133 expression in human gliomas
- (2008) Kouichi Tabu et al. CELL RESEARCH
- Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
- (2008) Robert P. Whitehead et al. INVESTIGATIONAL NEW DRUGS
- A Novel Histone Acetyltransferase Inhibitor Modulating Gcn5 Network: Cyclopentylidene-[4-(4′-chlorophenyl)thiazol-2-yl)hydrazone
- (2008) Franco Chimenti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Biotinyl-methyl 4-(amidomethyl)benzoate is a competitive inhibitor of human biotinidase
- (2008) Keyna A. Kobza et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started